Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is -45.21% vs -14.10% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 63.74% vs -72.28% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 19.81% vs 26.12% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is 37.14% vs -36.55% in Mar 2025
Compare Profit and Loss Results of Krebs Biochem
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
23.00
163.00
-140.00
-85.89%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
23.00
163.00
-140.00
-85.89%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
6.00
-6.00
-100.00%
Raw Materials Consumed
0.00
87.00
-87.00
-100.00%
Power & Fuel Cost
9.00
11.00
-2.00
-18.18%
Employee Cost
10.00
14.00
-4.00
-28.57%
Operating Expenses
2.00
14.00
-12.00
-85.71%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
5.00
-5.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
2.00
2.00
0.00
0.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
29.00
144.00
-115.00
-79.86%
Operating Profit (PBDIT) excl Other Income
-5.00
18.00
-23.00
-127.78%
Other Income
2.00
1.00
1.00
100.00%
Operating Profit (PBDIT)
-3.00
19.00
-22.00
-115.79%
Interest
7.00
5.00
2.00
40.00%
Profit before Depriciation and Tax
-10.00
14.00
-24.00
-171.43%
Depreciation
6.00
5.00
1.00
20.00%
Profit Before Taxation & Exceptional Items
-16.00
8.00
-24.00
-300.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
-16.00
8.00
-24.00
-300.00%
Provision for Tax
0.00
2.00
-2.00
-100.00%
Profit After Tax
-16.00
6.00
-22.00
-366.67%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
-297.00
25.00
-322.00
-1,288.00%
Profit Available for appropriations
-314.00
31.00
-345.00
-1,112.90%
Appropriations
-314.00
31.00
-345.00
-1,112.90%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
-7.85
4.82
-12.67
-262.86%
Profit And Loss - Net Sales
Net Sales 23.73 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -45.21% vs -14.10% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) -5.45 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 63.74% vs -72.28% in Mar 2025
Profit And Loss - Interest
Interest 7.09 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 19.81% vs 26.12% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax -16.93 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 37.14% vs -36.55% in Mar 2025
